Principles of Surgical Oncology in the Elderly

Clinics in Geriatric Medicine

Volumn 28, Issue 1, 2012, Pages 51-71

  Zbar, Andrew P ^a   Gravitz, Aviad ^a   Audisio, Riccardo A ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cancer; Chemoprevention; Elderly; Treatment

Indexed keywords

CARBOPLATIN; DOCETAXEL; PACLITAXEL;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER MORTALITY; CANCER SURGERY; COLORECTAL CANCER; COMPREHENSIVE GERIATRIC ASSESSMENT; DIARRHEA; ESOPHAGUS CANCER; GERIATRIC ASSESSMENT; GERIATRIC SURGERY; HEAD AND NECK CANCER; HUMAN; LYMPH NODE DISSECTION; LYMPHEDEMA; NEPHROTOXICITY; REVIEW; STOMACH CANCER; THROMBOCYTOPENIA;

AGED; AGED, 80 AND OVER; AGING; COMBINED MODALITY THERAPY; DECISION MAKING; EVIDENCE-BASED MEDICINE; FEMALE; GERIATRIC ASSESSMENT; GERIATRICS; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PATIENT CARE PLANNING;

EID: 84856783833     PISSN: 07490690     EISSN: 18798853     Source Type: Journal    
DOI: 10.1016/j.cger.2011.09.002     Document Type: Review

References (193)

1. Jernal A., Murray T., Samuels A., et al. Cancer statistics 2003. CA Cancer J Clin 2003, 53:5-26.
2. Davis D.L., Dinse G.E., Hoel D.G. Decreasing cardiovascular disease and increasing cancer among whites in the United States from 1973 through 1987: good news and bad news. JAMA 1984, 271:431-437.
3. Leading causes of death in the United States, 1973 vs 1999. J Natl Cancer Inst 2002, 94:1742.
4. Projections of the total resident population by 5-year age groups and sex with special age categories. Middle Series 2025-2045 2000, Population Projection Program Population Division US Census Bureau, Washington (DC), Publication no. NP-T3-F.
5. Gómez Portilla A., Martínez de Lecea C., Cendoya I., et al. Prevalence and treatment of oncologic disease in the elderly: an impending challenge. Rev Esp Enferm Dis 2008, 11:706-715.
6. Yancik R., Havlik R.J., Wesley M.N., et al. Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol 1996, 6:399-412.
7. Ogle K.S., Swanson G.M., Woods N., et al. Cancer and comorbidity: redefining chronic diseases. Cancer 2000, 88:653-663.
8. Read W.L., Tierney R.L., Page N.C., et al. Differential prognostic impact of comorbidity. J Clin Oncol 2004, 22:3099-3103.
9. Sekue I., Fukuda X., Kumitoh H., et al. Cancer chemotherapy in the elderly. Jpn J Clin Oncol 1998, 28:463-473.
10. Wasil T., Lichtman S.M., Gupta V., et al. Radiation therapy in cancer patients 80 years of age or older. Am J Clin Oncol 2000, 23:526-530.
11. Audisio R.A., Bozzetti F., Gennari R., et al. The surgical management of elderly cancer patients: recommendations of the SIOG surgical task force. Eur J Cancer 2004, 40:926-938.
12. Trimble E.L., Carter C.L., Cain D., et al. Representation of older patients in cancer treatment trials. Cancer 1994, 74:2208-2214.
13. Townsley C.A., Selby R., Siu L.L. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol 2005, 23:3112-3124.
14. Aapro M.S., Köhne C.H., Cohen H.J., et al. Never too old?. Age should not be a barrier to enrollment in cancer clinical trials. Oncologist 2005, 10:198-204.
15. Piantanelli L. Cancer and aging: from the kinetics of biological parameters and the kinetics of cancer incidence and mortality. Ann N Y Acad Sci 1988, 521:99-101.
16. Anisimov V.N. Biology of aging and cancer. Cancer Control 2007, 14:23-31.
17. Malaguarnera I., Ferlito L., DiMauro S., et al. Immunosenescence and cancer: a review. Arch Gerontol Geriatr 2001, 32:77-93.
18. Whiteside T.L. Cell-mediated dysregulation in malignancy and its therapeutic immunopotentiation. Immunology for surgeons 2002, 263-280. Springer-Verlag, London. A.P. Zbar, K.I. Bland, K.N. Syrigos (Eds.).
19. Fulop T., Larbi A., Kotb R., et al. Aging, immunity, and cancer. Discov Med 2011, 11:537-550.
20. Wildiers H., Kunkler I., Biganzoli L., et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 2007, 8:1101-1115. International Society of Geriatric Oncology.
21. Papamichael D., Audisio R., Horiot J.C., et al. Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. Ann Oncol 2009, 20:5-16. SIOG.
22. Gretschel S., Estevez-Schwarz L., Hunerbein M., et al. Gastric cancer surgery in elderly patients. World J Surg 2006, 30:1468-1474.
23. Chang A.C., Lee J.S. Resection for esophageal cancer in the elderly. Thorac Surg Clin 2009, 19:333-343.
24. Bernardi D., Barzan L., Franchin G., et al. Treatment of head and neck cancer in elderly patients: state of the art and guidelines. Crit Rev Oncol Hematol 2005, 53:71-80.
25. Truong P.T., Bernstein V., Wai E., et al. Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer. Int J Radiat Oncol Biol Phys 2002, 54:794-803.
26. Neugut A.I., Fleischauer A.T., Sundararajan V., et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol 2002, 20:2643-2650.
27. Maas H.A., Janssen-Heijnen M.L., Olde Rikkert M.G., et al. Comprehensive geriatric assessment and its clinical impact in oncology. Eur J Cancer 2007, 43:2161-2169.
28. Pope D., Ramesh H., Gennari R., et al. Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol 2006, 15:189-197.
29. Shall we operate?. Preoperative assessment in elderly cancer patients (PACE can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol 2008, 65:156-163. PACE participants.
30. New classification of physical status. American society of anaesthesiologists. Anesthesiology 1963, 24:111.
31. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9:179-186.
32. Satariano W.A., Ragland D.R. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994, 120:104-110.
33. Mendoza T.R., Wang X.S., Cleeland C.S., et al. The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 1999, 85:1186-1196.
34. Audisio R.A., van Leeuwen B. When reporting on older patients with cancer, frailty information is needed. Ann Surg Oncol 2011, 18:4-5.
35. Kristjansson S.R., Nesbakken A., Jordhoy M.S., et al. Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study. Crit Rev Oncol Hematol 2010, 76:208-217.
36. Turrentine F.E., Wang H., Simpson V.B., et al. Surgical risk factors, morbidity and mortality in elderly patients. J Am Coll Surg 2006, 203:865-877.
37. Kristjansson S.R., Farinella E., Gaskell S., et al. Surgical risk and post-operative complications in older unfit cancer patients. Cancer Treat Rev 2009, 35:499-502.
38. Slaets J. Vulnerability in the elderly: frailty. Med Clin North Am 2006, 90:593-601.
39. Saliba D., Elliott M., Rubenstein L.Z., et al. The vulnerable elders survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc 2001, 49:1691-1699.
40. Podsiadlo D., Richardson S. The timed "up and go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991, 39:142-148.
41. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a national quality-of-life instrument for use in international clinical trials in oncology. J Nat Cancer Inst 1993, 85:365-376.
42. Bjordal K., de Graeff A., Fayers P.M., et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (E ORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 2000, 36:1796-1807.
43. Schuurmans H., Steverink N., Lindenberg S., et al. Old or frail: what tells us more?. J Gerontol A Biol Sci Med Sci 2004, 59:M962-M965.
44. Martin F.C., Brighton P. Frailty: different tools for different purposes?. Age Ageing 2008, 37:129-131.
45. Grube B.J., Hansen N.M., Ye W., et al. Surgical management of breast cancer in the elderly. Am J Surg 2001, 182:359-364.
46. Liang W., Burnett C.B., Rowland J.H., et al. Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction. J Clin Oncol 2002, 20:1008-1016.
47. Morrow M., Bucci C., Rademaker A. Medical contraindications are not a major factor in the underutilization of breast conserving therapy. J Am Coll Surg 1998, 186:269-274.
48. Mustacchi G., Ceccherini R., Milani S., et al. Tamoxifen alone versus adjuvant Tamoxifen for operable breast cancer of the elderly: long term results of the phase III randomized controlled multicenter GRETA trial. Ann Oncol 2003, 14:414-420. Italian Cooperative Group GRETA.
49. Robertson J.F.R., Todd J.H., Ellis I.O., et al. Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer. Br Med J 1988, 297:511-514.
50. Gazet J.C., Ford H.T., Coombes R.C., et al. Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. Eur J Surg Oncol 1994, 20:207-214.
51. Fentiman I.S., Christiaens M.R., Paridaens R., et al. Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy. Eur J Cancer 2003, 39:309-316. EORTC.
52. Kenny F.S., Robertson J.F.R., Ellis I.O., et al. Long-term follow-up of elderly patients randomized to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancer. Breast 1998, 7:35-39.
53. Fennessy M., Bates T., MacRae K., et al. Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer. Br J Surg 2004, 91:699-704.
54. Hind D., Wyld L., Reed M.W. Surgery, with or without tamoxifen, versus tamoxifen alone for older women with operable breast cancer. Cochrane review. Br J Cancer 2007, 96:1025-1029.
55. Edge S.B., Gold K., Berg C.D., et al. Outcomes and Preferences for Treatment in Older Women Nationwide Study Research Team. Outcomes and preferences for treatment in older women nationwide study research team: patient and provider characteristics that affect the use of axillary dissection in older women with stage I-II breast carcinoma. Cancer 2002, 94:2534-2541.
56. Bland K.I., Scottg-Conner C.E., Menck H., et al. Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Database Study of patterns of omission and implications for survival. J Am Coll Surg 1999, 188:586-595.
57. Lupe K., Truong P.T., Alexander C., et al. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection. Int J Radiat Oncol Biol Phys 2011, [Epub ahead of print].
58. Fisher C.J., Egan M.K., Smith P., et al. Histopathology of breast cancer in relation to age. Br J Cancer 1997, 75:593-596.
59. Gennari R., Curigliano G., Rotmensz N. Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients. Cancer 2004, 101:1302-1310.
60. Martelli G., Miceli R., Daidone M.G., et al. Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol 2011, 18:125-138.
61. Mandelblatt J.S., Edge S.B., Meropol N.J., et al. Sequelae of axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma. Cancer 2002, 95:2445-2454.
62. Martelli G., Boracchi P., De Palo M., et al. A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up. Ann Surg 2005, 242:1-6.
63. Rudenstam C.M., Zahrieh D., Forbes J.F., et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of the International Breast Cancer Study Group Trial 10-93. J Clin Oncol 2006, 24:337-344. International Breast Cancer Study Group.
64. Gennari R., Rotmensz N., Perego E., et al. Sentinel node biopsy in elderly breast cancer patients. Surg Oncol 2004, 13:193-196.
65. Gajdos C., Tartter P.I., Bleiweiss I.J., et al. The consequence of undertreating breast cancer in the elderly. J Am Coll Surg 2001, 192:698-707.
66. Blackman S.B., Lash T.L., Fink A.K., et al. Advanced age and adjuvant tamoxifen prescription in early-stage breast carcinoma patients. Cancer 2002, 95:2465-2472.
67. Du X.L., Osborne C., Goodwin J.S. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol 2002, 20:4636-4642.
68. Muir C.S., Fraumeni J.F., Doll R. The interpretation of time trends. Cancer Surv 1994, 19:5-21. 20.
69. Kowalski L.P., Alcantara P.S., Magrin J., et al. A case-control study on complications and survival in elderly patients undergoing major head and neck surgery. Am J Surg 1994, 168:485-490.
70. Bliss R., Patel N., Guniea A., et al. Age is no contraindication to thyroid surgery. Age Ageing 1999, 28:363-366.
71. Magnano M., De Stefani A., Usai A. Carcinoma of the larynx in the elderly: analysis of potentially significant prognostic variables. Aging 1999, 11:316-322.
72. Boruk M., Chernobilsky B.M., Rosenfeld R.M., et al. Age as a prognostic factor for complications of major head and neck surgery. Arch Otolaryngol Head Neck Surg 2005, 13:605-609.
73. Koch W.M., Patel H., Brennan J., et al. Squamous cell carcinoma of the head and neck in the elderly. Arch Otolaryngol Head Neck Surg 1995, 121:262-265.
74. Sarini J., Fournier C., Lefebvre J.L., et al. Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases. Arch Otolaryngol Head Neck Surg 2001, 127:1089-1092.
75. Morgan R.F., Hirata R.M., Jaques D.A., et al. Head and neck surgery in the aged. Am J Surg 1982, 144:449-451.
76. Sanabria A., Carvalho A.L., Vartanian J.G., et al. Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol 2007, 14:1449-1457.
77. Piccirillo J.F. Importance of comorbidity in head and neck cancer. Laryngoscope 2000, 110:593-602.
78. Piccirillo J.F., Tierney R.M., Costas I., et al. Prognostic importance of comorbidity in a hospital-based cancer registry. J Am Med Assoc 2004, 29:2441-2447.
79. Sesterhenn A.M., Schotte T.L., Bauhofer A., et al. Head and neck cancer surgery in the elderly: outcome evaluation with the McPeek score. Ann Otol Rhinol Laryngol 2011, 120:110-115.
80. Lusinchi A., Bourhis J., Wibault P., et al. Radiation therapy for head and neck cancers in the elderly. Int J Radiat Biol Phys 1990, 18:819-823.
81. Metges J.P., Eschwege F., de Crevoisier R., et al. Radiotherapy in head and neck cancer in the elderly: a challenge. Crit Rev Oncol Hematol 2000, 34:195-203.
82. Syrigos K.N., Karachalios D., Karapanagiotou E.M., et al. Head and neck cancer in the elderly: an overview on the treatment modalities. Cancer Treat Rev 2009, 35:237-245.
83. Jones A.S., Husband D., Rowley H. Radical radiotherapy for squamous cell carcinoma of the larynx, oropharynx and hypopharynx: patterns of recurrence, treatment and survival. Clin Otolaryngol Allied Sci 1998, 23:496-511.
84. Logemann J.A., Pauloski B.R., Rademaker A.W., et al. Speech and swallowing rehabilitation for head and neck cancer patients. Oncology (Williston Park) 1997, 11:651-656. 659.
85. Sanders A.D., Blom E.D., Singer M.I., et al. Reconstructive and rehabilitative aspects of head and neck cancer in the elderly. Otolaryngol Clin North Am 1990, 23:1159-1168.
86. Al Mardini M. Prosthetic rehabilitation of the head and neck: the state of the art. Curr Opin Otolaryngol Head Neck Surg 2009, 17:253-257.
87. Smith R.B., Sniezek J.C., Weed D.T., et al. Utilization of free tissue transfer in head and neck surgery. Otolaryngol Head Neck Surg 2007, 137:182-191.
88. Jones A.S., Goodyear P.W., Ghosh S., et al. Extensive neck node metastases (N3) in head and neck squamous carcinoma: is radical treatment warranted?. Otolaryngol Head Neck Surg 2011, 144:29-35.
89. Zabdrodsky M., Calabrese L., Tosoni A., et al. Major surgery in elderly head and neck cancer patients: immediate and long-term surgical results and complication rates. Surg Oncol 2004, 13:249-255.
90. Lacouurreye O., Brasnu D., Perie S., et al. Supracricoid partial laryngectomies in the elderly: mortality, complications and functional outcome. Laryngoscope 1998, 108:237-242.
91. Shestak K.C., Jones N.F., Wu W., et al. Effect of advanced age and medical disease on the outcome of microvascular reconstruction for head and neck defects. Head Neck 1992, 14:14-18.
92. Bridger A.G., O'Brien C.J., Lee K.K. Advanced patient age should not preclude the use of free-flap reconstruction for head and neck cancer. Am J Surg 1994, 168:425-428.
93. Malata C.M., Cooter R.D., Batchelor A.G., et al. Microvascular free-tissue transfers in elderly patients: the Leeds experience. Plast Reconstr Surg 1996, 98:1234-1241.
94. Shaari C.M., Buchbinder D., Costantino P.D., et al. Complications of microvascular head and neck surgery in the elderly. Arch Otolaryngol Head Neck Surg 1998, 124:407-411.
95. Pompei S., Tedesco M., Pozzi M., et al. Age as a risk factor in cervicofacial reconstruction. J Exp Clin Cancer Res 1998, 18:209-212.
96. Moorthy S.S., Radpour S. Management of anesthesia in geriatric patients undergoing head and neck surgery. Ear Nose Throat J 1999, 78:496-498.
97. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000, 48:7-16.
98. Nguyen L.N., Ang K.K. Radiotherapy for cancer of the head and neck: altered fractionation regimens. Lancet Oncol 2002, 3:693-701.
99. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006, 368:843-854. Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group.
100. Zachariah B., Balducci L., Venkattaramanabaji G.V., et al. Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side-effects. Int J Radiat Oncol Biol Phys 1997, 39:1125-1129.
101. Mitsuhashi N., Hayakawa K., Yamakawa M., et al. Cancer in patients aged 90 years or older: radiation therapy. Radiology 1999, 211:829-833.
102. Schofield C.P., Sykes A.J., Slevin N.J., et al. Radiotherapy for head and neck cancer in elderly patients. Radiother Oncol 2003, 69:34-37.
103. Oguchi M., Ikeda H., Watanabe T., et al. Experiences of 23 patients > or = 90 years of age treated with radiation therapy. Int J Radiat Oncol Biol Phys 1998, 41:407-413.
104. Agiris A., Li Y., Murphy B.A., et al. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy. J Clin Oncol 2004, 22:262-268.
105. Takeda J., Tanaka T., Koufuji K., et al. Gastric cancer surgery in patients aged at least 80 years old. Hepatogastroenterology 1994, 41:516-520.
106. Audisio R.A., Veronesi P., Ferrario L., et al. Elective surgery of gastrointestinal tumours in the aged. Ann Oncol 1997, 8:317-327.
107. Gretschel S., Estevez-Schwarz L., Hünerbein M., et al. Gastric cancer surgery in elderly patients. World J Surg 2006, 30:1468-1474.
108. Conglio A., Tiberio G.A., Busti M., et al. Surgical treatment for gastric carcinoma in the elderly. J Surg Oncol 2004, 88:201-205.
109. Pisanu A., Montisci A., Piu A., et al. Curative surgery for gastric cancer in the elderly: treatment decisions, surgical morbidity, mortality, prognosis and quality of life. Tumouri 2007, 93:478-484.
110. Bittner R., Butters M., Ulrich M., et al. Total gastrectomy: updated operative mortality and long-term survival with particular reference to patients older than 70 years of age. Ann Surg 1996, 224:37-42.
111. Otsuji E., Fujiyama J., Takagi T., et al. Results of total gastrectomy with extended lymphadenectomy for gastric cancer in elderly patients. J Surg Oncol 2005, 91:232-236.
112. Benchimol D., Le Goff D., Fotiadis C., et al. La chirurgie d'éxerèse du cancer de l'estomac après 75 ans. Chirurgie 1989, 115:436-445.
113. Eguchi T., Fujii M., Takayama T. Mortality for gastric cancer in elderly patients. J Surg Oncol 2003, 84:132-136.
114. Hoffman K.E., Neville B.A., Memon H.J., et al. Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness. Cancer 2011, [Epub ahead of print].
115. Choi J.Y., Shim K.N., Roh S.H., et al. Clinicopathological characteristics of gastric cancer and survival improvement by surgical treatment in the elderly. Korean J Gastroenterol 2011, 58:9-19.
116. Cho G.S., Kim W., Kim H.H., et al. Multicentre study of the safety of laparoscopic subtotal gastrectomy for gastric cancer in the elderly. Br J Surg 2009, 96:1437-1442.
117. Sun Y., Yang Y. Study for the quality of life following total gastrectomy of gastric carcinoma. Hepatogastroenterology 2011, 58:669-673.
118. Stein H.J., Sendler A., Siewert J.R. Site-dependent resection techniques for gastric cancer. Surg Oncol Clin N Am 2002, 11:405-414.
119. Memon M.A., Subramanya M.S., Khan S., et al. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg 2011, 253:900-911.
120. Wu A.W., Xu G.W., Wang H.Y., et al. Neoadjuvant chemotherapy versus none for resectable gastric cancer. Cochrane Database Syst Rev 2007, 4. CD005047.
121. Saif M.W., Makrilla N., Zalonis A., et al. Gastric cancer in the elderly: an overview. Eur J Surg Oncol 2010, 36:709-717.
122. Cijs T.M., Verhoef C., Steyerberg E.W., et al. Outcome of esophagectomy for cancer in elderly patients. Ann Thorac Surg 2010, 90:900-907.
123. Jougon J.B., Ballester M., Duffy J., et al. Esophagectomy for cancer in the patient aged 70 years and older. Ann Thorac Surg 1997, 63:1423-1427.
124. Alexiou C., Beggs D., Salama F.D., et al. Surgery for esophageal cancer in elderly patients: the view from Nottingham. J Thorac Cardiovasc Surg 1998, 116:545-553.
125. Sabel M.S., Smith J.L., Nava H.R., et al. Esophageal resection for carcinoma in patients older than 70 years. Ann Surg Oncol 2002, 9:210-214.
126. Bonavina L., Incarbone R., Saino G., et al. Clinical outcome and survival after esophagectomy for carcinoma in elderly patients. Dis Esophagus 2003, 16:90-93.
127. Ruol A., Portale G., Zaninotto G., et al. Results of esophagectomy for esophageal cancer in elderly patients: age has little influence on outcome and survival. J Thorac Cardiovasc Surg 2007, 133:1186-1192.
128. Ruol A., Portale G., Castoro C., et al. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer. Ann Surg Oncol 2007, 14:3243-3250.
129. Shimada H., Shiratori T., Okazumi S., et al. Surgical outcome of elderly patients 75 years of age and older with thoracic esophageal carcinoma. World J Surg 2007, 31:773-779.
130. Morita M., Egashira A., Yoshida R., et al. Esophagectomy in patients 80 years of age and older with carcinoma of the thoracic esophagus. J Gastroenterol 2008, 43:345-351.
131. Takeno S., Takahashi Y., Watanabe S., et al. Esophagectomy in patients aged over 80 years with esophageal cancer. Hepatogastroenterology 2008, 55:453-456.
132. Nakui M., Chino O., Ozawa S. Treatment of esophageal cancer in elderly patients. Gan To Kagaku Ryoho 2010, 37:2813-2816.
133. Elsayed H., Whittle I., McShane J., et al. The influence of age on mortality and survival in patients undergoing oesophagogastrectomies. A seven-year experience in a tertiary centre. Interact Cardiovasc Thorac Surg 2010, 11:65-69.
134. Yang H.X., Ling L., Zhang X., et al. Outcome of elderly patients with oesophageal squamous cell carcinoma after surgery. Br J Surg 2010, 97:862-867.
135. Zehetner J., Lipham J.C., Ayazi S., et al. Esophagectomy for cancer in octogenarians. Dis Esophagus 2010, 23:666-669.
136. Fogh S.E., Yu A., Kubicek G.J., et al. Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy?. Int J Radiat Oncol Biol Phys 2011, 80:1372-1376.
137. Tekkis P.P., Poloniecki J.D., Thompson M.R., et al. ACPGBI Colorectal Cancer Study 2002: part A - unadjusted outcomes. Part B - risk adjusted outcomes. The ACPGBI Colorectal Cancer Model Access September 15, 2011. http://www.acpgbi.org.uk.
138. Surgery for colorectal cancer in elderly patients. Lancet 2000, 356:968-974. Colorectal Cancer Collaborative Group.
139. Koperna T., Kisser M., Schulz F. Emergency surgery for colon cancer in the aged. Arch Surg 1997, 132:1032-1037.
140. Ficorella C., Cannita K., Ricevuto E. The adjuvant therapy of colonic carcinoma in old age. Minerva Med 1999, 90:232-233.
141. Pavlidis T.E., Marakis G., Ballas K., et al. Safety of bowel resection for colorectal surgical emergency in the elderly. Colorectal Dis 2006, 8:657-662.
142. Law W.L., Choi H.K., Chu K.W. Comparison of stenting with emergency surgery as palliative treatment for obstructing primary left-sided colorectal cancer. Br J Surg 2003, 90:1429-1433.
143. Ng K.C., Law W.L., Lee Y.M., et al. Self expanding metallic stents as a bridge to surgery versus emergency resection for obstructing left sided colorectal cancer: A case-matched study. J Gastrointest Surg 2006, 10:798-803.
144. Carne P.W., Frye J.N., Robertson G.M., et al. Stents or open operation for palliation of colorectal cancer: a retrospective, cohort study of perioperative outcome and long-term survival. Dis Colon Rectum 2004, 47:1455-1461.
145. van Hooft J.E., Fockens P., Marinelli A.W., et al. Premature closure of the Dutch Stent-in I study. Lancet 2006, 368:1573-1574.
146. Audisio R.A., Zbar A.P., Johnson F.E. Clinical trials for colonic stents. Lancet 2007, 369(9557):188-189.
147. Targownik L.E., Spiegel B.M., Sack J., et al. Colonic stent vs. emergency surgery for management of acute left-sided malignant colonic obstruction: a decision analysis. Gastrointest Endosc 2004, 60:865-874.
148. Guo M.G., Feng Y., Zheng Q., et al. Comparison of self-expanding metal stents and urgent surgery for left-sided malignant colonic obstruction in elderly patients. Dig Dis Sci 2011, 56:2706-2710.
149. Selinger C.P., Ramesh J., Martin D.F. Long-term success of colonic stent insertion is influenced by indication but not by length of stent or site of obstruction. Int J Colorectal Dis 2011, 26:215-218.
150. Trompetas V., Saunders M., Gossage J., et al. Shortcomings in colonic stenting to palliate large bowel obstruction from extracolonic malignancies. Int J Colorectal Dis 2010, 25:851-854.
151. Chautard J., Alves A., Zalinski S., et al. Laparoscopic colorectal surgery in elderly patients: a matched case-control study in 178 patients. J Am Coll Surg 2008, 206:255-260.
152. Pinto R.A., Ruiz D., Edden Y., et al. How reliable is laparoscopic colorectal surgery compared with laparotomy for octogenarians?. Surg Endosc 2011, 25:2692-2698.
153. Fiscon V., Portale G., Migliorini G., et al. Laparoscopic resection of colorectal cancer in elderly patients. Tumori 2010, 96:704-708.
154. Robinson C.N., Balentine C.J., Marshall C.L., et al. Minimally invasive surgery improves short-term outcomes in elderly colorectal cancer patients. J Surg Res 2011, 166:182-188.
155. Verheijen P.M., Stevenson A.R., Lumley J.W., et al. Laparoscopic resection of advanced colorectal cancer. Br J Surg 2011, 98:427-430.
156. Nozaki I., Kubo Y., Kurita A., et al. Laparoscopic colectomy for colorectal cancer patients with previous abdominal surgery. Hepatogastroenterology 2008, 55:943-946.
157. Casillas S., Delaney C.P., Senagore A.J., et al. Does conversion of a laparoscopic colectomy adversely affect patient outcome?. Dis Colon Rectum 2004, 47:1680-1685.
158. Shankar A., Taylor I. Treatment of colorectal cancer in patients aged over 75. Eur J Surg Oncol 1998, 24:391-395.
159. Catena F., Pasqualini E., Tonini V., et al. Emergency surgery of colorectal cancer in patients older than 80 years of age. Ann Ital Chir 2002, 73:173-180.
160. Au H.J., Mulder K.E., Fields A.L. Systematic review of management of colorectal cancer in elderly patients. Clin Colorectal Cancer 2003, 3:165-171.
161. Fietkau R., Zettl H., Klöcking S., et al. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry. Strahlenther Onkol 2004, 180:478-487.
162. Chiappa A., Zbar A.P., Bertani E., et al. Surgical treatment of advanced colorectal cancer in the elderly. Chir Ital 2005, 57:589-596.
163. Richter P., Milanowski W., Bucki K., et al. Age as a prognostic factor in colorectal cancer treatment. Przegl Lek 2005, 62:1440-1443.
164. Heriot A.G., Tekkis P.P., Smith J.J., et al. Prediction of postoperative mortality in elderly patients with colorectal cancer. Dis Colon Rectum 2006, 49:816-824.
165. Isobe H., Takasu N., Mizutani M., et al. Management of colorectal cancer in elderly patients over 80 years old. Nippon Ronen Igakkai Zasshi 2007, 44:599-605.
166. Basili G., Lorenzetti L., Biondi G., et al. Colorectal cancer in the elderly. Is there a role for safe and curative surgery?. ANZ J Surg 2008, 78:466-470.
167. Aparicio T., Navazesh A., Boutron I., et al. Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment. Crit Rev Oncol Hematol 2009, 71:249-257.
168. Matasar M.J., Sundararajan V., Grann V.R., et al. Management of colorectal cancer in elderly patients: focus on the cost of chemotherapy. Drugs Aging 2004, 21:113-133.
169. Chiappa A., Bertani E., Zbar A.P., et al. Surgery for advanced colorectal cancer in elderly patients with special emphasis for radio-chemotherapy role. Hepatogastroenterology 2007, 54:740-745.
170. Bouvier A.M., Jooste V., Bonnetain F., et al. Adjuvant treatments do not alter the quality of life in elderly patients with colorectal cancer: a population-based study. Cancer 2008, 113:879-886.
171. Pasetto L.M., Friso M.L., Pucciarelli S., et al. Rectal cancer neoadjuvant treatment in elderly patients. Anticancer Res 2006, 26:3913-3923.
172. Mantello G., Berardi R., Cardinali M., et al. Feasibility of preoperative chemoradiation in rectal cancer patients aged 70 and older. J Exp Clin Cancer Res 2005, 24:541-546.
173. Hotta T., Takifuji K., Yokoyama S., et al. Rectal cancer surgery in the elderly: analysis of consecutive 158 patients with stage III rectal cancer. Langenbecks Arch Surg 2007, 392:549-558.
174. Lorchel F., Peignaux K., Créhange G., et al. Preoperative radiotherapy in elderly patients with rectal cancer. Gastroenterol Clin Biol 2007, 31:436-441.
175. Fiorica F., Cartei F., Carau B., et al. Adjuvant radiotherapy on older and oldest elderly rectal cancer patients. Arch Gerontol Geriatr 2009, 49:54-59.
176. Reddy N., Yu J., Fakih M.G. Toxicities and survival among octogenarians and nonagenarians with colorectal cancer treated with chemotherapy or concurrent chemoradiation therapy. Clin Colorectal Cancer 2007, 6:362-366.
177. Agostini M., Pasetto L.M., Pucciarelli S., et al. Glutathione S-transferase P1 Ile105Val polymorphism is associated with haematological toxicity in elderly rectal cancer patients receiving preoperative chemoradiotherapy. Drugs Aging 2008, 25:531-539.
178. Habr-Gama A., Perez R.O., Proscurshim I., et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 2006, 10:1319-1328.
179. Bege T., Lelong B., Esterni B., et al. The learning curve for the laparoscopic approach to conservative mesorectal excision for rectal cancer: lessons drawn from a single institution's experience. Ann Surg 2010, 251:249-253.
180. Del Rio P., Dell'Abate P., Gomes B., et al. Analysis of risk factors for complications in 262 cases of laparoscopic colectomy. Ann Ital Chir 2010, 81:21-30.
181. Akiyoshi T., Kuroyanagi H., Oya M., et al. Short-term outcomes of laparoscopic rectal surgery for primary rectal cancer in elderly patients: is it safe and beneficial?. J Gastrointest Surg 2009, 13:1614-1618.
182. Ogiso S., Yamaguchi T., Hata H., et al. Evaluation of factors affecting the difficulty of laparoscopic anterior resection for rectal cancer: "narrow pelvis" is not a contraindication. Surg Endosc 2011, 25:1907-1912.
183. de Campos-Lobato L.F., Alves-Ferreira P.C., Geisler D.P., et al. Benefits of laparoscopy: does the disease condition that indicated colectomy matter?. Am Surg 2011, 77:527-533.
184. Brown C.J., Raval M.J. Advances in minimally invasive surgery in the treatment of colorectal cancer. Expert Rev Anticancer Ther 2008, 8:111-123.
185. Kurian A., Suryadevara S., Ramaraju D., et al. In-hospital and 6-month mortality rates after open elective vs open emergent colectomy in patients older than 80 years. Dis Colon Rectum 2011, 54:467-471.
186. Marks J.H., Kawun U.B., Hamdan W., et al. Redefining contraindications to laparoscopic colorectal resection for high-risk patients. Surg Endosc 2008, 22:1899-1904.
187. Frasson M., Braga M., Vignali A., et al. Benefits of laparoscopic colorectal resection are more pronounced in elderly patients. Dis Colon Rectum 2008, 51:296-300.
188. Blair S.L., Schwarz R.E. Advanced age does not contribute to increased risks or poor outcome after major abdominal operations. Am Surg 2001, 67:1123-1127.
189. Monson K., Litvak D.A., Bold R.J. Surgery in the aged population: surgical oncology. Arch Surg 2003, 138:1061-1067.
190. Evers B.M., Townsend C.M., Thompson J.C. Organ physiology of aging. Surg Clin North Am 1994, 74:23-39.
191. Webb T.P., Duthie E. Geriatrics for surgeons: infusing life into an aging subject. J Surg Educ 2008, 65:91-94.
192. Van Leeuwen B.L., Kristjansson S.R., Audisio R.A. Should specialized oncogeriatric surgeons operate older unfit cancer patients?. Eur J Surg Oncol 2010, 36:S18-S22.
193. Cheema F.N., Abraham N.S., Berger D.H., et al. Novel approaches to perioperative assessment and intervention may improve long-term outcomes after colorectal cancer resection in older adults. Ann Surg 2011, 253:867-874.